HOME >> BIOLOGY >> NEWS
Gene therapy protects mice from the effects of whole-body irradiation

BALTIMORE, June 3 University of Pittsburgh School of Medicine researchers have successfully protected mice against the damaging effects that radiation can have on bone marrow using gene therapy. Based on these results, the researchers believe this approach may be able to protect first responders in the event of a radiological accident or the detonation of a crude radiological weapon, or "dirty bomb." The findings are being presented at the American Society of Gene Therapy annual meeting in Baltimore, May 31 to June 4.

Since the events of Sept.11, there has been growing concern that terrorists may use a dirty bomb--a conventional explosive wrapped in radiological material--or attack a nuclear power facility to disperse high-dose radiation across a populated area. Experts believe a significant number of the population would die within 30 days of exposure to a high dose of radiation from such an event, which has prompted the federal government to fund efforts to develop medical interventions against radiological and nuclear threats.

In this study, Pitt researchers used gene therapy to deliver the compound manganese superoxide dismutase-plasmid liposome (MnSOD-PL) to the cells of female mice. Twenty-four hours later, groups of mice that received the treatment and control mice that did not were exposed to varying doses of whole body radiation. Following irradiation, the mice were weighed daily and observed for signs of irradiation-induced damage to their bone marrow. Control mice irradiated at the higher doses lost weight and died fairly rapidly due to bone marrow damage. In contrast, mice treated with the MnSOD-PL gene therapy showed no changes in body weight, had little bone-marrow damage, and lived longer compared to the control irradiated mice.

According to corresponding author Joel S. Greenberger, M.D., professor and chair of the department of radiation oncology and co-director of the Lung Cancer Center at the University of Pittsburgh Cancer
'"/>


3-Jun-2006


Page: 1 2

Related biology news :

1. Testosterone replacement therapy: How safe for aging men?
2. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... ... January 23, 2020 , ... Asymmetrex ... Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire, ARMI is the ... partner organizations from industry, government, academia and the non-profit sector to develop ...
(Date:1/10/2020)... ... January 09, 2020 , ... Cutting Edge Spine, a ... 510(K) clearance and commercial launch of the latest addition to its bioactive portfolio ... EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced material supplied by Invibio Biomaterial Solutions. ...
(Date:1/2/2020)... Texas (PRWEB) , ... January 02, 2020 , ... ... custom and semi-custom aqueous reagents, chemicals, and medias, as well as medical grade ... and cell- and tissue-based product manufacturers. , “We are excited to bring ...
Breaking Biology News(10 mins):
(Date:12/31/2019)... ... December 31, 2019 , ... ... product development lab in Maryland. Emphasis will be in expanding capabilities ... capabilities, Vici Health Sciences will be well positioned to meet the growing demand ...
(Date:12/27/2019)... ... December 27, 2019 , ... Leak Detection ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited to ... Following acquisition by CLJ Holdings in February, 2019, a comprehensive and aggressive reorganization ...
(Date:12/18/2019)... Ariz. (PRWEB) , ... December 17, 2019 , ... ... has received its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the ... closest competitors, Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) have ...
(Date:12/14/2019)... ... December 12, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... The new LDA LT80 (LOW TEMPERATURE -80C) helium leak testing system is designed ...
Breaking Biology Technology:
Cached News: